肝炎診断検査の世界市場レポート 2025年

肝炎診断検査市場規模は、今後数年間で力強い成長が見込まれます。2029年にはCAGR6.0％で62億4,000万米ドルに成長します。予測期間の成長は、世界の健康安全保障への懸念、人口増加と都市化、テーラーメイド検査戦略、排除プログラムの重視、ヘルスケア支出の増加に起因すると考えられます。予測期間における主な動向としては、検査技術の進歩、異なる肝炎ウイルスに対するマルチプレックス検査、分子診断の統合、デジタルヘルスソリューション、戦略的提携やパートナーシップなどが挙げられます。

輸血と献血の増加は肝炎診断検査市場の成長を促進すると予想されます。輸血と献血は、個人が自発的に血液を提供し、その血液が採取、検査され、病状、手術、事故、病気などのために追加の血液成分を必要とする患者に投与される、というつながりのあるプロセスです。肝炎診断検査は、献血や輸血の前に血液を徹底的にスクリーニングし、患者の安全を確保するために不可欠です。例えば、2023年8月、英国を拠点とする団体であるRoyal College of Pathologistsは、輸血は入院患者に対して最も一般的に行われる処置であり、英国では年間200万近くの血液成分が発行され輸血され、3億英ポンド（3億9,069万米ドル）以上の費用がかかっていると報告しています。従って、輸血と献血の増加は肝炎診断検査市場の拡大を支えています。

世界の肝炎患者の急増も、肝炎診断検査市場の成長を後押しする重要な要因です。肝臓の炎症を特徴とする肝炎は、重大な健康リスクをもたらし、さまざまな症状や合併症を引き起こす可能性があります。肝炎の正確な診断検査は、肝炎感染の存在を特定・確認し、タイムリーな介入と効果的な疾患管理を可能にする上で極めて重要です。例えば、B型肝炎財団によると、2023年には年間推定150万人が肝炎に罹患し、これらの疾病がもたらす持続的な課題が浮き彫りになっています。肝炎の罹患率の増加は、早期発見と管理における信頼性の高い診断検査の重要性を強調しており、市場における肝炎診断検査の需要に拍車をかけています。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 市場- 金利、インフレ、地政学、コロナ、回復が市場に与える影響を含むマクロ経済シナリオ

第5章 世界の成長分析と戦略分析フレームワーク

• 世界肝炎診断検査PESTEL分析（政治、社会、技術、環境、法的要因、促進要因、抑制要因）
• 最終用途産業の分析
• 世界の肝炎診断検査市場：成長率分析
• 世界の肝炎診断検査市場の実績：規模と成長, 2019-2024
• 世界の肝炎診断検査市場の予測：規模と成長, 2024-2029, 2034F
• 世界肝炎診断検査総アドレス可能市場（TAM）

第6章 市場セグメンテーション

• 世界の肝炎診断検査市場テストの種類別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 血液検査
• 画像検査
• 肝生検
• 世界の肝炎診断検査市場：技術別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 酵素免疫測定法（ELISA）
• 迅速診断テスト（RDT）
• ポリメラーゼ連鎖反応（PCR）
• 等温核酸増幅検査（INAAT）
• その他のテクノロジー
• 世界の肝炎診断検査市場：エンドユーザー別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 病院
• 診断検査室
• 血液銀行
• その他のエンドユーザー
• 世界の肝炎診断検査市場、血液検査の種類別の細分化、実績と予測, 2019-2024, 2024-2029F, 2034F
• 血清学的検査
• ポリメラーゼ連鎖反応（PCR）検査
• 酵素免疫測定法（ELISA）
• 世界の肝炎診断検査市場、画像検査の種類別のサブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• 超音波
• コンピュータ断層撮影（CT）
• 磁気共鳴画像（MRI）
• 世界の肝炎診断検査市場肝生検の種類別のサブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• 経皮生検
• 経頸静脈生検
• 腹腔鏡下生検

第7章 地域別・国別分析

• 世界の肝炎診断検査市場：地域別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 世界の肝炎診断検査市場：国別、実績と予測, 2019-2024, 2024-2029F, 2034F

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• 肝炎診断検査市場：競合情勢
• 肝炎診断検査市場：企業プロファイル
  • Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
  • Danaher Corporation Overview, Products and Services, Strategy and Financial Analysis
  • Siemens Healthineers AG Overview, Products and Services, Strategy and Financial Analysis
  • Roche Diagnostics Overview, Products and Services, Strategy and Financial Analysis

第31章 その他の大手企業と革新的企業

• Quest Diagnostics Incorporated
• Grifols S.A
• Hologic Inc.
• BioMerieux SA
• Beckman Coulter Inc.
• Bio-Rad Laboratories Inc.
• SD Biosensor Co. Ltd.
• QIAGEN N.V.
• DiaSorin S.p.A.
• Randox Laboratories Ltd.
• Luminex Corporation
• Fujirebio Diagnostics Inc.
• Trivitron Healthcare Private Limited
• Trinity Biotech plc
• MP Biomedicals LLC

第32章 世界の市場競合ベンチマーキングとダッシュボード

第33章 主要な合併と買収

第34章 最近の市場動向

第35章 市場の潜在力が高い国、セグメント、戦略

• 肝炎診断検査市場2029：新たな機会を提供する国
• 肝炎診断検査市場2029：新たな機会を提供するセグメント
• 肝炎診断検査市場2029：成長戦略
  • 市場動向に基づく戦略
  • 競合の戦略

第36章 付録

Hepatitis diagnostic tests are medical procedures and laboratory analyses designed to identify and diagnose infections caused by hepatitis viruses, including hepatitis A, B, C, D, and E. These tests are essential for detecting the presence of hepatitis viruses or specific antibodies in a patient's blood or other bodily fluids. The primary goal is to confirm the infection, determine its type, assess severity, and monitor its progression.

The main categories of hepatitis diagnostic tests include blood tests, imaging tests, and liver biopsy. Blood tests involve examining blood samples to assess various constituents such as blood cells, proteins, enzymes, hormones, antibodies, and other chemicals. Various technologies are utilized in these tests, including enzyme-linked immunosorbent assay (ELISA), rapid diagnostic tests, polymerase chain reaction (PCR), isothermal nucleic acid amplification tests, and others. These diagnostic tools find applications in diverse healthcare settings such as hospitals, diagnostic laboratories, blood banks, and other medical facilities.

The hepatitis diagnostic tests market research report is one of a series of new reports from The Business Research Company that provides hepatitis diagnostic tests market statistics, including hepatitis diagnostic tests industry global market size, regional shares, competitors with a hepatitis diagnostic tests market share, detailed hepatitis diagnostic tests market segments, market trends, and opportunities, and any further data you may need to thrive in the hepatitis diagnostic test industry. This hepatitis diagnostic tests market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The hepatitis diagnostic tests market size has grown strongly in recent years. It will grow from $4.64 billion in 2024 to $4.95 billion in 2025 at a compound annual growth rate (CAGR) of 6.5%. The growth in the historic period can be attributed to globalization of healthcare, government initiatives, high disease burden, increased blood safety measures, public health campaigns.

The hepatitis diagnostic tests market size is expected to see strong growth in the next few years. It will grow to $6.24 billion in 2029 at a compound annual growth rate (CAGR) of 6.0%. The growth in the forecast period can be attributed to global health security concerns, population growth and urbanization, tailored testing strategies, emphasis on elimination programs, increasing healthcare spending. Major trends in the forecast period include advancements in testing technologies, multiplex testing for different hepatitis viruses, integration of molecular diagnostics, digital health solutions, strategic collaborations and partnerships.

The increasing number of blood transfusions and donations is expected to drive growth in the hepatitis diagnostic test market. Blood transfusions and donations are connected processes in which individuals voluntarily provide blood, which is then collected, tested, and administered to patients in need of additional blood components due to medical conditions, surgeries, accidents, or illnesses. Hepatitis diagnostic tests are essential for thoroughly screening blood before donation or transfusion, ensuring patient safety. For instance, in August 2023, the Royal College of Pathologists, a UK-based organization, reported that blood transfusion is the most commonly performed procedure for hospitalized patients, with nearly 2 million blood components issued and transfused annually in England, costing over £300 million ($390.69 million). Thus, the growing number of blood transfusions and donations supports the expansion of the hepatitis diagnostic test market.

The surge in hepatitis cases globally is another key factor propelling the growth of the hepatitis diagnostic tests market. Hepatitis, characterized by liver inflammation, poses significant health risks and can lead to various symptoms and complications. Accurate diagnostic tests for hepatitis are crucial in identifying and confirming the presence of hepatitis infections, enabling timely interventions and effective disease management. For instance, according to the Hepatitis B Foundation in 2023, an estimated 1.5 million people contract hepatitis infections annually, highlighting the persistent challenge posed by these diseases. The growing incidence of hepatitis underlines the critical importance of reliable diagnostic tests in early detection and management, thereby fueling the demand for hepatitis diagnostic tests in the market.

Dominant players in the hepatitis diagnostic test market are concentrating on innovating automated immunoassays, exemplified by the Elecsys HCV Duo, to enhance customer service reliability. Automated immunoassays represent laboratory techniques utilizing automated systems and specialized instruments to conduct various phases of the immunoassay process, encompassing sample handling, reagent mixing, incubation, detection, and result calculation. For instance, in July 2023, Roche Diagnostics India, a biotechnology research company based in India, introduced Elecsys HCV Duo. This advanced solution represents India's maiden fully automated immunoassay available commercially, facilitating the simultaneous and independent evaluation of hepatitis C virus (HCV) antigen and antibody levels from a single human plasma or serum sample. Moreover, this approach streamlines the diagnostic procedure, enabling single-specimen testing and potentially reducing the number of necessary follow-up visits, consequently alleviating the burden on healthcare systems.

In October 2024, The Bank of Nova Scotia, a Canada-based company, acquired Bio-Rad Laboratories Inc. for an undisclosed amount. This acquisition allows The Bank of Nova Scotia to diversify its portfolio by integrating Bio-Rad Laboratories' expertise in hepatitis diagnostic testing. Bio-Rad Laboratories Inc., a U.S.-based company, is known for its products and services in diagnostic testing for hepatitis.

Major companies operating in the hepatitis diagnostic tests market report are Thermo Fisher Scientific Inc., Abbott Laboratories, Danaher Corporation, Siemens Healthineers AG, Roche Diagnostics, Quest Diagnostics Incorporated, Grifols S.A, Hologic Inc., BioMerieux SA, Beckman Coulter Inc., Bio-Rad Laboratories Inc., SD Biosensor Co. Ltd., QIAGEN N.V., DiaSorin S.p.A., Randox Laboratories Ltd., Luminex Corporation, Fujirebio Diagnostics Inc., Trivitron Healthcare Private Limited, Trinity Biotech PLC, MP Biomedicals LLC, R-Biopharm AG, Creative Diagnostics, InBios International Inc., Dia.Pro Diagnostic Bioprobes srl, DIALAB GmbH

North America was the largest region in the hepatitis diagnostic tests market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the hepatitis diagnostic tests market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the hepatitis diagnostic tests market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The hepatitis diagnostic test market consists of revenues earned by entities by providing diagnostic services such as liver ultrasound, computerized tomography (CT) scans, and antibody tests. The market value includes the value of related goods sold by the service provider or included within the service offering. The hepatitis diagnostic test market also includes sales of laboratory equipment, reagents, and assay components that are used in providing hepatitis diagnostic test services. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Hepatitis Diagnostic Tests Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on hepatitis diagnostic tests market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for hepatitis diagnostic tests ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The hepatitis diagnostic tests market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Test Type: Blood Tests; Imaging Tests; Liver Biopsy
• 2) By Technology: Enzyme-Linked Immunosorbent Assay (ELISA); Rapid Diagnostic Tests (RDTs); Polymerase Chain Reaction (PCR); Isothermal Nucleic Acid Amplification Test (INAAT); Other Technologies
• 3) By End User: Hospitals; Diagnostic Laboratories; Blood Bank; Other End Users
• Subsegments:
• 1) By Blood Tests: Serological Tests; Polymerase Chain Reaction (PCR) Tests; Enzyme-Linked Immunosorbent Assays (ELISA)
• 2) By Imaging Tests: Ultrasound; Computed Tomography (CT); Magnetic Resonance Imaging (MRI)
• 3) By Liver Biopsy: Percutaneous Biopsy; Transjugular Biopsy; Laparoscopic Biopsy
• Companies Mentioned: Thermo Fisher Scientific Inc.; Abbott Laboratories; Danaher Corporation; Siemens Healthineers AG; Roche Diagnostics
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Hepatitis Diagnostic Tests Market Characteristics

3. Hepatitis Diagnostic Tests Market Trends And Strategies

4. Hepatitis Diagnostic Tests Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Covid And Recovery On The Market

5. Global Hepatitis Diagnostic Tests Growth Analysis And Strategic Analysis Framework

• 5.1. Global Hepatitis Diagnostic Tests PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Hepatitis Diagnostic Tests Market Growth Rate Analysis
• 5.4. Global Hepatitis Diagnostic Tests Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Hepatitis Diagnostic Tests Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Hepatitis Diagnostic Tests Total Addressable Market (TAM)

6. Hepatitis Diagnostic Tests Market Segmentation

• 6.1. Global Hepatitis Diagnostic Tests Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Blood Tests
• Imaging Tests
• Liver Biopsy
• 6.2. Global Hepatitis Diagnostic Tests Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Enzyme-Linked Immunosorbent Assay (ELISA)
• Rapid Diagnostic Tests (RDTs)
• Polymerase Chain Reaction (PCR)
• Isothermal Nucleic Acid Amplification Test (INAAT)
• Other Technologies
• 6.3. Global Hepatitis Diagnostic Tests Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospitals
• Diagnostic Laboratories
• Blood Bank
• Other End Users
• 6.4. Global Hepatitis Diagnostic Tests Market, Sub-Segmentation Of Blood Tests, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Serological Tests
• Polymerase Chain Reaction (PCR) Tests
• Enzyme-Linked Immunosorbent Assays (ELISA)
• 6.5. Global Hepatitis Diagnostic Tests Market, Sub-Segmentation Of Imaging Tests, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Ultrasound
• Computed Tomography (CT)
• Magnetic Resonance Imaging (MRI)
• 6.6. Global Hepatitis Diagnostic Tests Market, Sub-Segmentation Of Liver Biopsy, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Percutaneous Biopsy
• Transjugular Biopsy
• Laparoscopic Biopsy

7. Hepatitis Diagnostic Tests Market Regional And Country Analysis

• 7.1. Global Hepatitis Diagnostic Tests Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Hepatitis Diagnostic Tests Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Hepatitis Diagnostic Tests Market

• 8.1. Asia-Pacific Hepatitis Diagnostic Tests Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Hepatitis Diagnostic Tests Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Hepatitis Diagnostic Tests Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Hepatitis Diagnostic Tests Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Hepatitis Diagnostic Tests Market

• 9.1. China Hepatitis Diagnostic Tests Market Overview
• 9.2. China Hepatitis Diagnostic Tests Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Hepatitis Diagnostic Tests Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Hepatitis Diagnostic Tests Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Hepatitis Diagnostic Tests Market

• 10.1. India Hepatitis Diagnostic Tests Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Hepatitis Diagnostic Tests Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Hepatitis Diagnostic Tests Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Hepatitis Diagnostic Tests Market

• 11.1. Japan Hepatitis Diagnostic Tests Market Overview
• 11.2. Japan Hepatitis Diagnostic Tests Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Hepatitis Diagnostic Tests Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Hepatitis Diagnostic Tests Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Hepatitis Diagnostic Tests Market

• 12.1. Australia Hepatitis Diagnostic Tests Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Hepatitis Diagnostic Tests Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Hepatitis Diagnostic Tests Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Hepatitis Diagnostic Tests Market

• 13.1. Indonesia Hepatitis Diagnostic Tests Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Hepatitis Diagnostic Tests Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Hepatitis Diagnostic Tests Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Hepatitis Diagnostic Tests Market

• 14.1. South Korea Hepatitis Diagnostic Tests Market Overview
• 14.2. South Korea Hepatitis Diagnostic Tests Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Hepatitis Diagnostic Tests Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Hepatitis Diagnostic Tests Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Hepatitis Diagnostic Tests Market

• 15.1. Western Europe Hepatitis Diagnostic Tests Market Overview
• 15.2. Western Europe Hepatitis Diagnostic Tests Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Hepatitis Diagnostic Tests Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Hepatitis Diagnostic Tests Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Hepatitis Diagnostic Tests Market

• 16.1. UK Hepatitis Diagnostic Tests Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Hepatitis Diagnostic Tests Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Hepatitis Diagnostic Tests Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Hepatitis Diagnostic Tests Market

• 17.1. Germany Hepatitis Diagnostic Tests Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Hepatitis Diagnostic Tests Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Hepatitis Diagnostic Tests Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Hepatitis Diagnostic Tests Market

• 18.1. France Hepatitis Diagnostic Tests Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Hepatitis Diagnostic Tests Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Hepatitis Diagnostic Tests Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Hepatitis Diagnostic Tests Market

• 19.1. Italy Hepatitis Diagnostic Tests Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Hepatitis Diagnostic Tests Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Hepatitis Diagnostic Tests Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Hepatitis Diagnostic Tests Market

• 20.1. Spain Hepatitis Diagnostic Tests Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Hepatitis Diagnostic Tests Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Hepatitis Diagnostic Tests Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Hepatitis Diagnostic Tests Market

• 21.1. Eastern Europe Hepatitis Diagnostic Tests Market Overview
• 21.2. Eastern Europe Hepatitis Diagnostic Tests Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Hepatitis Diagnostic Tests Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Hepatitis Diagnostic Tests Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Hepatitis Diagnostic Tests Market

• 22.1. Russia Hepatitis Diagnostic Tests Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Hepatitis Diagnostic Tests Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Hepatitis Diagnostic Tests Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Hepatitis Diagnostic Tests Market

• 23.1. North America Hepatitis Diagnostic Tests Market Overview
• 23.2. North America Hepatitis Diagnostic Tests Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Hepatitis Diagnostic Tests Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Hepatitis Diagnostic Tests Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Hepatitis Diagnostic Tests Market

• 24.1. USA Hepatitis Diagnostic Tests Market Overview
• 24.2. USA Hepatitis Diagnostic Tests Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Hepatitis Diagnostic Tests Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Hepatitis Diagnostic Tests Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Hepatitis Diagnostic Tests Market

• 25.1. Canada Hepatitis Diagnostic Tests Market Overview
• 25.2. Canada Hepatitis Diagnostic Tests Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Hepatitis Diagnostic Tests Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Hepatitis Diagnostic Tests Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Hepatitis Diagnostic Tests Market

• 26.1. South America Hepatitis Diagnostic Tests Market Overview
• 26.2. South America Hepatitis Diagnostic Tests Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Hepatitis Diagnostic Tests Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Hepatitis Diagnostic Tests Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Hepatitis Diagnostic Tests Market

• 27.1. Brazil Hepatitis Diagnostic Tests Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Hepatitis Diagnostic Tests Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Hepatitis Diagnostic Tests Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Hepatitis Diagnostic Tests Market

• 28.1. Middle East Hepatitis Diagnostic Tests Market Overview
• 28.2. Middle East Hepatitis Diagnostic Tests Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Hepatitis Diagnostic Tests Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Hepatitis Diagnostic Tests Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Hepatitis Diagnostic Tests Market

• 29.1. Africa Hepatitis Diagnostic Tests Market Overview
• 29.2. Africa Hepatitis Diagnostic Tests Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Hepatitis Diagnostic Tests Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Hepatitis Diagnostic Tests Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Hepatitis Diagnostic Tests Market Competitive Landscape And Company Profiles

• 30.1. Hepatitis Diagnostic Tests Market Competitive Landscape
• 30.2. Hepatitis Diagnostic Tests Market Company Profiles
  • 30.2.1. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Danaher Corporation Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Siemens Healthineers AG Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Roche Diagnostics Overview, Products and Services, Strategy and Financial Analysis

31. Hepatitis Diagnostic Tests Market Other Major And Innovative Companies

• 31.1. Quest Diagnostics Incorporated
• 31.2. Grifols S.A
• 31.3. Hologic Inc.
• 31.4. BioMerieux SA
• 31.5. Beckman Coulter Inc.
• 31.6. Bio-Rad Laboratories Inc.
• 31.7. SD Biosensor Co. Ltd.
• 31.8. QIAGEN N.V.
• 31.9. DiaSorin S.p.A.
• 31.10. Randox Laboratories Ltd.
• 31.11. Luminex Corporation
• 31.12. Fujirebio Diagnostics Inc.
• 31.13. Trivitron Healthcare Private Limited
• 31.14. Trinity Biotech plc
• 31.15. MP Biomedicals LLC

32. Global Hepatitis Diagnostic Tests Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Hepatitis Diagnostic Tests Market

34. Recent Developments In The Hepatitis Diagnostic Tests Market

35. Hepatitis Diagnostic Tests Market High Potential Countries, Segments and Strategies

• 35.1 Hepatitis Diagnostic Tests Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Hepatitis Diagnostic Tests Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Hepatitis Diagnostic Tests Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer